» Articles » PMID: 35919263

Survey on Arterial Hypertension Management: a Report from the ESC Council for Cardiology Practice and the ESC Council on Hypertension

Overview
Date 2022 Aug 3
PMID 35919263
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To explore the management of hypertensive patients by general cardiologists a few months after the European Society of Cardiology (ESC)-European Society of Hypertension (ESH) Guidelines publication.

Methods And Results: A survey based on a 26-point questionnaire was sent to ∼69 000 worldwide ESC members, a few months after the ESC-ESH Guidelines publication. A total of 1458 responses were collected via a web-based form. Among them, 68% were men, 48% were below 45 years old, and 60% were from Europe. Current guidelines have been read, at least partially, by 92.8%. Measurement of blood pressure (BP) is mostly done using the auscultatory method (58.8%) while unattended BP is rarely performed. Different bladder cuffs are not available for different arm circumferences for 27% of responders. Routine workup in hypertensive patients includes more often 12 leads ECG (97.7%) and echocardiography (79.6%). Only 30.9% of responders systematically assess the cardiovascular risk by the SCORE system and orthostatic hypotension is systematically researched by only 39.1%. Respondents consider that BP target of 140/90 mmHg is achievable in 60-80% of patients and 130/80 mmHg in 40-60%. Guidelines are considered too tight to be achievable by 15.6%, while 77.4% consider they are exactly right. Low patient's compliance, awareness of hypertension (HT) risk, and, at a lower degree, physician inertia, represent the main treatment challenges in reaching BP goals to most respondents, while treatment effectiveness is not in question. The present survey demonstrates specific gaps in HT management that need attention in clinical practice.

Citing Articles

Independent relationship between sleep apnea-specific hypoxic burden and glucolipid metabolism disorder: a cross-sectional study.

Li C, Peng Y, Zhu X, Liu Y, Zou J, Zhu H Respir Res. 2024; 25(1):214.

PMID: 38762509 PMC: 11102635. DOI: 10.1186/s12931-024-02846-7.


Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.

Tsukamoto S, Kobayashi K, Toyoda M, Hatori N, Kanaoka T, Wakui H Hypertens Res. 2023; 47(3):628-638.

PMID: 37848562 DOI: 10.1038/s41440-023-01464-y.


Open Up your Science in .

Back M, Banach M, Braunschweig F, De Rosa S, Gimelli A, Kahan T Eur Heart J Open. 2022; 1(1):oeab021.

PMID: 35923168 PMC: 9242074. DOI: 10.1093/ehjopen/oeab021.

References
1.
Niiranen T, Rissanen H, Johansson J, Jula A . Overall cardiovascular prognosis of isolated systolic hypertension, isolated diastolic hypertension and pulse pressure defined with home measurements: the Finn-home study. J Hypertens. 2014; 32(3):518-24. DOI: 10.1097/HJH.0000000000000070. View

2.
Tocci G, Figliuzzi I, Presta V, Attalla El Halabieh N, Citoni B, Coluccia R . Adding markers of organ damage to risk score models improves cardiovascular risk assessment: Prospective analysis of a large cohort of adult outpatients. Int J Cardiol. 2017; 248:342-348. DOI: 10.1016/j.ijcard.2017.07.078. View

3.
Juraschek S, Taylor A, Wright Jr J, Evans G, Miller 3rd E, Plante T . Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Hypertension. 2020; 75(3):660-667. PMC: 7261502. DOI: 10.1161/HYPERTENSIONAHA.119.14309. View

4.
Williams B, Mancia G . Ten Commandments of the 2018 ESC/ESH HTN Guidelines on Hypertension in Adults. Eur Heart J. 2019; 39(33):3007-3008. DOI: 10.1093/eurheartj/ehy439. View

5.
So R, Shinohara K, Aoki T, Tsujimoto Y, Suganuma A, Furukawa T . Effect of Recruitment Methods on Response Rate in a Web-Based Study for Primary Care Physicians: Factorial Randomized Controlled Trial. J Med Internet Res. 2018; 20(2):e28. PMC: 5824098. DOI: 10.2196/jmir.8561. View